Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

News / Press Releases
: News / Press Releases

News / Press Releases

Latest News

Tonix Pharmaceuticals Expands Pipeline with Mid-Stage Biologic Candidate TNX-1300 for Cocaine Intoxication

Read Press Release

Upcoming Event

American Society of Clinical Psychopharmacology

Scottsdale, Arizona

View Events

Upcoming Event

Second Chance Digital Impact Recipient Gala

National Harbor, Maryland

View Events